Tetracycline Solution Stability via Dehydrating Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Tetracycline solutions, particularly doxycycline, face stability issues due to epimerization, leading to the formation of 4-epidoxycycline, which reduces antimicrobial activity and product lifespan, and existing strategies fail to completely prevent this phenomenon without refrigeration or using unsuitable solvents.
Innovation Solution
The use of dehydrating agents like ethyl acetate and acetic anhydride to remove water from the doxycycline hyclate formulation, combined with solvents such as propylene glycol and polyethylene glycol, creates stable solutions that inhibit epimerization, allowing storage at room temperature for extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If tetracycline is formulated in solution form, then administration convenience and mass treatment capability are improved, but epimerization occurs leading to reduced antimicrobial activity and product stability
Solution Approach 1:
The patent changes the chemical parameters of the formulation by incorporating specific excipients (glycerol, propylene glycol, 2-pyrrolidone, n-methyl-2-pyrrolidone, dimethylacetamide, dimethylformamide) and controlling pH levels to create a chemical environment that suppresses epimerization while maintaining tetracycline solubility and antimicrobial activity
Solution Approach 2:
The patent creates a composite pharmaceutical formulation by combining tetracycline with multiple stabilizing excipients and solvents in specific proportions, forming a synergistic system that prevents epimerization while maintaining the desired therapeutic properties and solution stability
2Reliability
If refrigeration is used to slow epimerization, then product stability is improved, but storage complexity and distribution costs increase
Solution Approach 1:
The patent modifies the chemical composition parameters of the formulation to include stabilizing excipients that shift the epimerization equilibrium, allowing the product to maintain stability at room temperature without requiring refrigeration infrastructure
3Reliability
If water content is reduced to prevent epimerization, then epimer formation is reduced, but solubility of tetracycline is compromised
Solution Approach 1:
The patent formulates a composite system combining multiple solvents and hydrophilic excipients that collectively provide both water-like solubility enhancement and epimerization prevention, achieving a balance between maintaining tetracycline dissolution and suppressing epimer formation
Solution Approach 2:
The patent optimizes the concentration ratios and chemical composition parameters of the excipients and solvents to achieve the optimal balance between solubility enhancement and epimerization suppression, ensuring adequate tetracycline dissolution while maintaining product stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach significantly reduces the formation of epimers, maintaining the stability and antimicrobial efficacy of tetracycline solutions for over three years at room temperature, ensuring product stability and safety for human and veterinary use.
Implementation Method 1
The use of dehydrating agents like ethyl acetate and acetic anhydride to remove water from the doxycycline hyclate formulation
Implementation Method 2
combined with solvents such as propylene glycol and polyethylene glycol, creates stable solutions that inhibit epimerization
Data Source
AI summary
The present invention relates to stable pharmaceutical compositions of tetracyclines in solution, together with the method for obtaining them and their use for manufacturing a drug for humans or animals for the prevention and/or treatment of conditions in which the tetracyclines show themselves to be effective. The formulations of the present invention use, as method of stabilisation, the incorporation of dehydrating agents or mixtures thereof in acceptable proportions together with other pharmaceutical excipients.